|
|
|
|
Published online before print
November 7, 2006, 10.1101/gr.5674706 Genome Res. 17:50-60, 2007 ©2007 by Cold Spring Harbor Laboratory Press; ISSN 1088-9051/07 $5.00
Letter Evolution of Chlamydia trachomatis diversity occurs by widespread interstrain recombination involving hotspots1 Center for Immunobiology and Vaccine Development, Childrens Hospital Oakland Research Institute, Oakland California 94609, USA; 2 Centro de Bacteriologia, Instituto Nacional de Saúde, Lisboa 1649-016, Portugal; 3 T-10 Theoretical Biology and Biophysics, MS-K710 Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA; 4 Department of Medicine and Biomedical Sciences, University of California at San Francisco School of Medicine, San Francisco, California 94143, USA
Chlamydia trachomatis is an obligate intracellular bacterium of major public health significance, infecting over one-tenth of the worlds population and causing blindness and infertility in millions. Mounting evidence supports recombination as a key source of genetic diversity among free-living bacteria. Previous research shows that intracellular bacteria such as Chlamydiaceae may also undergo recombination but whether this plays a significant evolutionary role has not been determined. Here, we examine multiple loci dispersed throughout the chromosome to determine the extent and significance of recombination among 19 laboratory reference strains and 10 present-day ocular and urogenital clinical isolates using phylogenetic reconstructions, compatibility matrices, and statistically based recombination programs. Recombination is widespread; all clinical isolates are recombinant at multiple loci with no two belonging to the same clonal lineage. Several reference strains show nonconcordant phylogenies across loci; one strain is unambiguously identified as recombinantly derived from other reference strain lineages. Frequent recombination contrasts with a low level of point substitution; novel substitutions relative to reference strains occur less than one per kilobase. Hotspots for recombination are identified downstream from ompA, which encodes the major outer membrane protein. This widespread recombination, unexpected for an intracellular bacterium, explains why strain-typing using one or two genes, such as ompA, does not correlate with clinical phenotypes. Our results do not point to specific events that are responsible for different pathogenicities but, instead, suggest a new approach to dissect the genetic basis for clinical strain pathology with implications for evolution, host cell adaptation, and emergence of new chlamydial diseases.
Chlamydia trachomatis is the primary bacterial cause of preventable blindness and sexually transmitted diseases (STD) worldwide (World Health Organization 2001
C. trachomatis serotyping is based on the antigenic major outer membrane protein (MOMP), and differentiates 19 serovars or strains (including genovariant Ja), which are grouped into three seroclasses: B Class (B, Ba, D, Da, E, L1, L2, L2a); C Class (A, C, H, I, Ia, J, Ja, K, L3), and Intermediate Class (F and G) (Wang and Grayston 1991a
Relatively little is known about the C. trachomatis genetic factors that may be involved in tissue tropism, pathogenesis, and evolution. This is largely due to its intracellular nature and the inability to genetically manipulate the organism. However, genome sequencing of two of the 19 reference strains of C. trachomatis, D/UW-3 (Stephens et al. 1998
The only other evidence for recombination in C. trachomatis is confined to a single gene, ompA. Previous examples included visually detected ompA mosaics comprised of two trachoma strains or two urogenital strains (Dean et al. 1992
Recombination has also been reported for the obligate intracellular organisms Rickettsia and Wolbachia. In the human pathogen Rickettsia, genomic analysis revealed infrequent recombination (Jiggins 2006 We provide evidence that interstrain recombination is rampant in this organism and is the dominant source of genetic diversification. Ten of ten clinical isolates are recombinants at multiple loci with no two belonging to the same clonal lineage. We identify two statistically significant hotspots for recombination downstream from ompA, the study of which could eventually allow the mechanism by which C. trachomatis recombinant evolution occurs to be discovered.
Phylogenetic and genomic loci analyses of C. trachomatis reference strains and clinical isolates Seventeen loci ( 40,000 bp or 4% of the chromosome) were selected for sequencing in the C. trachomatis genome based on three criteria: (1) substantial variation in particular loci that was predicted based on microarray studies of 15 reference strains (Brunelle et al. 2004
Figure 1 shows the results of analysis of the 17 loci for the 19 reference strains. Phylogenetic trees constructed from the different loci are incongruent (Fig. 2; Supplemental Fig. 1), suggesting recombination. We analyzed the nonsynonymous/synonymous substitution ratios (
Guided by the Da/TW-448 structure, we selected seven of the 17 loci that represented four well-separated regions of the chromosome for sequencing the 10 clinical isolates. Trees representing the phylogenetic reconstructions are incongruent for all genomic regions of all clinical isolates (Supplemental Fig. 3). The two least incongruent loci, CT049 and pmpC (Supplemental Fig. 3A and B, respectively), differ only in deeper nodes corresponding to recombination in the evolution of the reference strains, but not more recently in the clinical isolates. Other pairs of loci indicate recombination in the evolution of at least some of the reference strains and all of the clinical isolates. Similar analyses as for the reference strains, including dN/dS (Supplemental Fig. 4), although no dN/dS analysis was performed over specific peptide regions of a protein, %G:C content, and contingency matrices (data not shown), indicate that recombination was the likely explanation for the incongruent trees. These data indicate extensive recombination where each clinical isolate is a distinct mosaic (Fig. 3).
Determination of breakpoint regions for Da/TW-448 Based on the trees (Supplemental Fig. 1) and contingency matrices (data not shown), the proposed mosaic structure for Da/TW-448 involves four breakpoints (Fig. 1). Figure 4 shows the results of SimPlot analyses, which includes the maximum 2 test, that was used to determine the regions within which the breakpoints are most likely found. The Recombination Identification Program showed similar results (data not shown). Table 1 shows the calculation of P-values for the informative sites (i.e., sites where Da/TW-448 agrees with one putative donor strain on one side of the breakpoint region and agrees with a different putative donor on the other side; Fig. 4A1) that support each region. The 2x2 matrix for each region is denoted n for informative sites for each topology in each area, from which the Fishers Exact Test is calculated. Also shown is the total number of informative sites (t) and the number of breakpoint regions (c) used to analyze the sequence; the Bonferroni correction was used as the number of ways to distribute c in the intervals between the t sites (t 1 choose c). P-values for the informative sites occurring in a nonrecombinant area areP = 1 x 1039 for the first region (rs2 and the rs2/ompA IGR) and P = 6.6 x 1010 for the second (ompA and ompA/pbpB IGR) (Fig. 1; Table 1). Two other breakpoint regions between the yfh0_1/parB IGR and pmpD and between pmpI and CT049 are suggested, but the exact locations could not be determined as we did not sequence the regions between these loci (Fig. 1).
Based on these results, Figure 4A2 shows the most likely position of the first breakpoint region that is confined to a 254-bp area, while the second region is restricted to a 29-bp area. These two breakpoint regions are bounded by the outer most informative sites that support one of the three phylogenetic trees shown in Figure 4A4. Figure 5A1, 2 shows the nucleotide sequence of the 254-bp region, which includes a tRNA-Gly-2 with characteristic inverted repeats, a ribosomal binding site (RBS) and promotor sites, and the 29-bp region, respectively.
Determination of breakpoint regions for 10 C. trachomatis clinical isolates All 10 clinical isolates contain at least two breakpoint regions denoted by black arrows as shown in Figure 3, which are supported by phylogenetic trees (Supplemental Fig. 2) and contingency matrices (data not shown). Interestingly, two pairs of clinical strains with identical ompA sequences (G/CL-4 and G/CL-5; H/CL-6 and H/CL-7) have varying numbers of breakpoint regions composed of DNA descended from different reference strain lineages. G/CL-5 appears to be composed of trachoma strains B and C, which are known to infect the urogenital tract (Millman et al. 2006 G/CL-4 and Ja/CL-10 are discussed here in more detail as several clinical isolates share breakpoint regions with these strains in the continuous, sequenced region between rs2 and the ompA/pbpB IGR (Fig. 3). Based on SimPlot analyses (Fig. 4), G/CL-4 has two breakpoint regions with P-values of P = 1.2 x 1028 for the first region (rs2 and rs2/ompA IGR) and P = 8.6 x 1023 for the second (rs2/ompA IGR and ompA) (Fig. 4B1; Table 1). The most likely positions for the breakpoint regions are within a highly conserved stretch of 48 bp for the first region (Fig. 4B2) in proximity to an RBS, as shown in the nucleotide sequence in Figure 5B1, and within a highly conserved stretch of 98 bp for the second (Figs. 4B2, 5B2). The informative sites support the phylogenetic trees as shown in Figure 4B4. Figure 4 shows the two breakpoint regions for Ja/CL-10 with P = 7.3 x 1024 for the first region (ompA and rs2/ompA IGR) and P = 4.5 x 106 for the second (ompA/pbpB IGR) (Fig. 4C1; Table 1). The most likely position of the first and second breakpoint regions are within a highly conserved stretch of 44 bp (Figs. 4C2, 5C1) and 164 bp (Figs. 4C2, 5C2), respectively. The latter occurs in proximity to an RBS (Fig. 5C2). These regions are flanked by informative sites that support distinct phylogenetic trees (Fig. 4C4).
Chromosomal hotspots
Analysis of the genotype assignments in Figure 3 reveals that no two of the recombination events in this region involve the same combinations of genotypes. Moreover, the phylogenies (Supplemental Fig. 3) show that the corresponding horizontal transfers are between pairs of branches in the tree that are distinguished by reasonable (>60%) bootstrap support in at least one tree. We conclude that no two recombinations in this region are descended from a single ancestral event and can be treated as statistically independent. In fact, only one pair of events in clinical samples H/CL-6 and H/CL-7 plausibly shares any recombinant events since the time of divergence of the reference strains (Fig. 3).
To compute P-values for the two clusters, we considered a null hypothesis that the 16 events are distributed randomly over this continuous 3.7-kb sequence. However, the events within An analysis considering only variable sites resulted in even more significant P-values, indicating that the appearance of hotspots is not caused by the nonuniform distribution of variable sites (data not shown).
While recombination has been widely documented for extracellular or facultative intracellular organisms such as the genera Neisseria (Gibbs et al. 1989 Genetic recombination is the only plausible mechanism of generation of the reference strain Da/TW-448 and the 10 clinical mosaic strains, as the accumulation of point mutations was statistically highly improbable. In fact, 14 of the 16 breakpoint regions are located in one of the two clusters (Fig. 6), making it unlikely that the crossovers occurred at random. Consequently, we consider the 48-bp and 44-bp regions to be hotspots for interstrain recombination.
The observed pattern of mosaicism indicates statistically significant hotspots for recombination, which implies either a site-specific recombination mechanism or selection for the resulting recombinant genomes. However, the fact that the data are consistent with many breakpoint regions occurring at exactly the same location suggests the former, possibly in combination with the latter. The regions lack recognizable sequences such as Chi sites or direct target repeats that are associated with some of the best-studied mechanisms of gene mobility and rearrangement (Gomes et al. 2004
While recombination would seem unlikely for an obligate intracellular pathogen that is sequestered from other strains by inhabiting an intracytoplasmic vacuole, various types of genetic exchange would be consistent with the knowledge that DNA repair and recombination systems, including recBCD and xer enzymes, are well represented in the C. trachomatis genome (Supplemental Table 1). Simultaneous infections of a single host cell with two C. trachomatis strains in which fusion of the respective vacuoles occurs have been documented in in vitro systems (Ridderhof and Barnes 1989
Our study shows that ompA is not genetically linked with a great deal of the genome, including the PZ region that contains a tryptophan synthase that may correlate with tissue tropism (Caldwell et al. 2003
Traditional C. trachomatis classification based on polymorphisms in one or two genes appears to be too restrictive since the similarity of the clinical isolates with the corresponding reference strain is sometimes confined to only a single gene. This is the case for Ja/CL-10, where only the ompA gene matches genovariant Ja/UW-92 (Fig. 3), and is further supported by the fact that all circulating clinical isolates in this study reveal a different mosaic structure, even for those with identical ompA sequences (e.g., G/CL-4 and G/Cl-5, and H/CL-6 and H/CL-7) (Fig. 3). The contradictory results on the association between serotype or ompA-genotype and clinical findings reported in the literature (Workowski et al. 1994
A broader study may reveal the time scale in which a given clonal strain persists in disease populations. Considering that our results come from a survey involving
The degree of widespread recombination we describe far exceeds that for Rickettsia, the only other intracellular human pathogen in which recombination is known to occur. We speculate that comparative genomics of C. trachomatis reference strains and additional clinical isolates would readily allow the identification of other recombination sites and possibly the mechanism(s) for each. Based on our data (Figs. 1, 3), a clonal frame (Milkman and Bridges 1990 Recombination provides a mechanism where genes encoding polymorphic antigens, pathogenic factors, or proteins involved in cell appetence could hypothetically be transferred and confer biological advantages for the chlamydial receptor strain. Thus, our results do not point to specific events that are responsible for different pathogenicities but, instead, suggest a new way to dissect the genetic basis for the disease pathology of clinical strains. Our current understanding of C. trachomatis will have to be revised as present-day clinical isolates are used in in vitro and in vivo research studies in tandem with reference strains to decipher the molecular and genetic mechanisms involved in contemporary and emerging human chlamydial diseases. In addition, our findings suggest the need for an expansive genomic exploration of clonal populations of C. trachomatis as well as of other obligate intracellular pathogens that may also be undergoing extreme recombination.
C. trachomatis reference strains and clinical isolates The 19 reference strains (A/Har-13, B/TW-5, Ba/Apache-2, C/TW-3, D/UW-3, Da/TW-448, E/Bour, F/IC-Cal3, G/UW-57, H/UW-4, I/UW-12, Ia/IU-4168, J/UW-36, K/UW-31, L1/440, L2/434, L2a/TW-396, and L3/404), including genovariant Ja/UW-92 and 10 clinical isolates representing eight ompA genotypes (C, Da, E, 2 G, 2 H, I, Ia, and Ja) from women with trachoma or urogenital infections were analyzed. We designated each clinical isolate in alphabetical order as C/CL-1, Da/CL-2, etc.
Cell culture of all C. trachomatis strains was performed as previously described (Dean et al. 2000
Sequencing of genomic regions
Determination of %G:C content
Analysis of the molecular evolution of genomic regions
Phylogenetic and statistical analyses
Determination of breakpoint regions
The null hypothesis for recombination was that informative sites are drawn from a single distribution. A P-value for any specified breakpoint is given by Fishers Exact Test. Because breakpoints are not specified in advance, we applied a Bonferroni multiple test factor for the number of ways to choose breakpoints. This makes the test conservative because the different hypotheses corresponding to different breakpoints are highly correlated. Some choices of breakpoints will have very little power, further reducing the effective number of tests. A more complex calculation that avoids our conservative approximations is given by Halpern (2000) To support the recombination regions given by SimPlot and to accurately infer the phylogenetic relationships of the putative recombinant strains, the defined breakpoint regions were used to divide the alignments into delimited genomic regions, and phylogenetic trees were inferred by Neighbor-joining (Kimura-2-parameter) analysis.
For comparative purposes with data obtained using SimPlot, we also used the RIP (http://hiv-web.lanl.gov/) (Smith 1992
Statistical analyses of chromosomal hotspots
In this case, the test is not exact because the number of breakpoint regions detected in our 10 clinical sequences cannot exceed 10 in a given window bounded by informative sites, making our result more conservative. To this value, we apply a multiple-test correction (roughly a factor of 3000/44), because the 44-bp region was not specified in advance, resulting in P = 2.9 x 106. For the other cluster of 254 bp for seven clinical isolates, we have six events plus a seventh (G/CL-5) that is ignored because it could be outside that region. Our contingency table gives P = 9.4 x 104. Corrected by 3000/254, this gives a P = 0.011.
We thank Tim Read for critical review of the manuscript and Bette Korber for helpful comments and encouragement along the way. This research was supported by Fundação Para a Ciência e Tecnologia and FEDER (POCTI/39822/MGI/2001) (MJB) and Public Health Service Grants from the National Institutes of Health, R01-AI59647 (DD) and R01-AI39499 (DD).
5 Corresponding author.
E-mail ddean{at}chori.org; fax: (510) 450-7910. [Supplemental material is available online at www.genome.org. The sequence data from this study have been submitted to GenBank under accession numbers: AY884090AY884108 (for pmpA), AY884109AY884127 (for pmpB), AY299408AY299426 (for pmpD), AY967735AY967738 (for pmpE), AY887644AY887662 and DQ065739 DQ065748 (for pmpF), AY967739AY967757 (for pmpG), AY967759AY967761 (for pmpH), AY299427AY299445 (for pmpI), DQ065736DQ065738, DQ062749DQ062755, and DQ076723DQ076741 (for ORF CT049), DQ113596DQ113614 and DQ076742DQ076751 (for IGR rs2/ompA), DQ116393DQ116402 (for ompA), DQ113625 DQ113643 and DQ113615DQ113624 (for IGR [ompA/pbpB]), DQ151840 (for ORF CT166), DQ151841DQ151847 and DQ239937DQ239957 (for rs2), DQ151848DQ151854 (for yfh0_1 and IGR [yfh0_1/parB]). Clinical isolates have the following designation in GenBank: C/CL-1 (CS-362-07), Da/CL-2 (CS-431/04), E/CL-3 (I-174), G/CL-4 (CS-490/95), G/CL-5 (I-149), H/CL-6 (CS-121/96), H/CL-7 (I-139), I/CL-8 (I-24), Ia/CL-9 (CS-190/96), and Ja/CL-10 (S-91).] Article published online before print. Article and publication data are at http://www.genome.org/cgi/doi/10.1101/gr.5674706
Anttila, T., Saikku, P., Koskela, P., Bloigu, A., Dillner, J., Ikaheimo, I., Jellum, E., Lehtinen, M., Lenner, P., and Hakulinen, T., et al. 2001. Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma. JAMA 285: 4751. Baldo, L., Bordenstein, S., Wernegreen, J.J., and Werren, J.H. 2006. Widespread recombination throughout Wolbachia genomes. Mol. Biol. Evol. 23: 437449. Bishop, A.L., Baker, S., Jenks, S., Fookes, M., Gaora, P.O., Pickard, D., Anjum, M., Farrar, J., Hien, T.T., and Ivens, A., et al. 2005. Analysis of the hypervariable region of the Salmonella enterica genome associated with tRNA(leuX). J. Bacteriol. 187: 24692482. Boisvert, J.F., Koutsky, L.A., Suchland, R.J., and Stamm, W.E. 1999. Clinical features of Chlamydia trachomatis rectal infection by serovar among homosexually active men. Sex. Transm. Dis. 26: 392398.[Medline] Brayton, K.A., Palmer, G.H., Lundgren, A., Yi, J., and Barbet, A.F. 2002. Antigenic variation of Anaplasma marginale msp2 occurs by combinatorial gene conversion. Mol. Microbiol. 43: 11511159.[CrossRef][Medline] Brunelle, B.W., Nicholson, T.L., and Stephens, R.S. 2004. Microarray-based genomic surveying of gene polymorphisms in Chlamydia trachomatis. Genome Biol. 5: R42.[CrossRef][Medline] Brunham, R., Yang, C., Maclean, I., Kimani, J., Maitha, G., and Plummer, F. 1994. Chlamydia trachomatis from individuals in a sexually transmitted diseases core group exhibit frequent sequence variation in the major outer membrane protein (omp1) gene. J. Clin. Invest. 94: 458463.[Medline] Cadavid, D., Thomas, D.D., Crawley, R., and Barbour, A.G. 1994. Variability of a bacterial surface protein and disease expression in a possible mouse model of systemic Lyme borreliosis. J. Exp. Med. 179: 631642. Caldwell, H.D., Wood, H., Crane, D., Bailey, R., Jones, R.B., Mabey, D., Maclean, I., Mohammed, Z., Peeling, R., and Roshick, C., et al. 2003. Polymorphisms in Chlamydia trachomatis tryptophan synthase genes differentiate between genital and ocular isolates. J. Clin. Invest. 111: 17571769.[CrossRef][Medline] Carlson, J.H., Hughes, S., Hogan, D., Cieplak, G., Sturdevant, D.E., McClarty, G., Caldwell, H.D., and Belland, R.J. 2004. Polymorphisms in the Chlamydia trachomatis cytotoxin locus associated with ocular and genital isolates. Infect. Immun. 72: 70637072. Carlson, J.H., Porcella, S.F., McClarty, G., and Caldwell, H.D. 2005. Comparative genomic analysis of Chlamydia trachomatis oculotropic and genitotropic strains. Infect. Immun. 73: 64076418. . Centers for Disease Control Prevention. 2005. Tracking the hidden epidemics: Trends in STDs in the United States. Department of Health and Human Services, Atlanta, GA. Dean, D. 2002. Pathogenesis of chlamydial ocular infections. In Duanes foundations of clinical ophthalmology (eds. W. Tasman, and E.A. Jaeger,), pp. 122. Lippincott Williams & Wilkins, Philadelphia, PA. Dean, D. and Millman, K. 1997. Molecular and mutation trends analyses of omp1 alleles for serovar E of Chlamydia trachomatis. Implications for the immunopathogenesis of disease. J. Clin. Invest. 99: 475483.[Medline] Dean, D. and Powers, V.C. 2001. Persistent Chlamydia trachomatis infections resist apoptotic stimuli. Infect. Immun. 69: 24422447. Dean, D., Schachter, J., Dawson, C.R., and Stephens, R.S. 1992. Comparison of the major outer membrane protein variant sequence regions of B/Ba isolates: A molecular epidemiologic approach to Chlamydia trachomatis infections. J. Infect. Dis. 166: 383392.[Medline] Dean, D., Suchland, R., and Stamm, W. 2000. Evidence for long-term cervical persistence of Chlamydia trachomatis by omp1 genotyping. J. Infect. Dis. 182: 909916.[CrossRef][Medline] Dugan, J., Rockey, D.D., Jones, L., and Andersen, A.A. 2004. Tetracycline resistance in Chlamydia suis mediated by genomic islands inserted into the chlamydial inv-like gene. Antimicrob. Agents Chemother. 48: 39893995. Enright, M.C., Spratt, B.G., Kalia, A., Cross, J.H., and Bessen, D.E. 2001. Multilocus sequence typing of Streptococcus pyogenes and the relationships between emm type and clone. Infect. Immun. 69: 24162427. Feil, E.J. and Spratt, B.G. 2001. Recombination and the population structures of bacterial pathogens. Annu. Rev. Microbiol. 55: 561590.[CrossRef][Medline] Feil, E.J., Cooper, J.E., Grundmann, H., Robinson, D.A., Enright, M.C., Berendt, T., Peacock, S.J., Smith, J.M., Murphy, M., and Spratt, B.G., et al. 2003. How clonal is Staphylococcus aureus? J. Bacteriol. 185: 33073316. Frick, K.D., Basilion, E.V., Hanson, C.L., and Colchero, M.A. 2003. Estimating the burden and economic impact of trachomatous visual loss. Ophthalmic Epidemiol. 10: 121132.[CrossRef][Medline] Gibbs, C.P., Reimann, B.Y., Schultz, E., Kaufmann, A., Haas, R., and Meyer, T.F. 1989. Reassortment of pilin genes in Neisseria gonorrhoeae occurs by two distinct mechanisms. Nature 338: 651652.[CrossRef][Medline] Gomes, J.P., Bruno, W.J., Borrego, M.J., and Dean, D. 2004. Recombination in the genome of Chlamydia trachomatis involving the polymorphic membrane protein C gene relative to ompA and evidence for horizontal gene transfer. J. Bacteriol. 186: 42954306. Gomes, J.P., Nunes, A., Bruno, W.J., Borrego, M.J., Florindo, C., and Dean, D. 2006. Polymorphisms in the nine polymorphic membrane proteins of Chlamydia trachomatis across all serovars: Evidence for serovar da recombination and correlation with tissue tropism. J. Bacteriol. 188: 275286. Grimwood, J. and Stephens, R.S. 1999. Computational analysis of the polymorphic membrane protein superfamily of Chlamydia trachomatis and Chlamydia pneumoniae. Microb. Comp. Genomics 4: 187201.[Medline] Haake, D.A., Suchard, M.A., Kelley, M.M., Dundoo, M., Alt, D.P., and Zuerner, R.L. 2004. Molecular evolution and mosaicism of leptospiral outer membrane proteins involves horizontal DNA transfer. J. Bacteriol. 186: 28182828. Halpern, A.L. 2000. Multiple-changepoint testing for an alternating segments model of a binary sequence. Biometrics 56: 903908.[CrossRef][Medline] Hayes, L.J., Yearsley, P., Treharne, J.D., Ballard, R.A., Fehler, G.H., and Ward, M.E. 1994. Evidence for naturally occurring recombination in the gene encoding the major outer membrane protein of lymphogranuloma venereum isolates of Chlamydia trachomatis. Infect. Immun. 62: 56595663. Jiggins, F.M. 2006. Adaptive evolution and recombination of Rickettsia antigens. J. Mol. Evol. 62: 99110.[CrossRef][Medline] Kimura, M. 1980. A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences. J. Mol. Evol. 16: 111120.[CrossRef][Medline] Lavreys, L., Chohan, V., Overbaugh, J., Hassan, W., McClelland, R.S., Kreiss, J., Mandaliya, K., Ndinya-Achola, J., and Baeten, J.M. 2004. Hormonal contraception and risk of cervical infections among HIV-1-seropositive Kenyan women. AIDS 18: 21792184.[CrossRef][Medline] Lole, K.S., Bollinger, R.C., Paranjape, R.S., Gadkari, D., Kulkarni, S.S., Novak, N.G., Ingersoll, R., Sheppard, H.W., and Ray, S.C. 1999. Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination. J. Virol. 73: 152160. Lorenz, M.G. and Wackernagel, W. 1994. Bacterial gene transfer by natural genetic transformation in the environment. Microbiol. Rev. 58: 563602. Maiden, M.C., Bygraves, J.A., Feil, E., Morelli, G., Russell, J.E., Urwin, R., Zhang, Q., Zhou, J., Zurth, K., and Caugant, D.A., et al. 1998. Multilocus sequence typing: A portable approach to the identification of clones within populations of pathogenic microorganisms. Proc. Natl. Acad. Sci. 95: 31403145. Milkman, R. and Bridges, M.M. 1990. Molecular evolution of the Escherichia coli chromosome. III. Clonal frames. Genetics 126: 505517.[Abstract] Millman, K.L., Tavare, S., and Dean, D. 2001. Recombination in the ompA gene but not the omcB gene of Chlamydia contributes to serovar-specific differences in tissue tropism, immune surveillance, and persistence of the organism. J. Bacteriol. 183: 59976008. Millman, K., Black, C.M., Johnson, R.E., Stamm, W.E., Jones, R.B., Hook, E.W., Martin, D.H., Bolan, G., Tavaré, S., and Dean, D. 2004. Population-based genetic and evolutionary analysis of Chlamydia trachomatis urogenital strain variation in the United States. J. Bacteriol. 186: 24572465. Millman, K., Black, C.M., Stamm, W.E., Jones, R.B., Hook III, E.W., Martin, D.H., Bolan, G., Tavare, S., and Dean, D. 2006. Population-based genetic epidemiologic analysis of Chlamydia trachomatis serotypes and lack of association between ompA polymorphisms and clinical phenotypes. Microbes Infect. 8: 604611.[CrossRef][Medline] Morré, S.A., Rozendaal, L., van Valkengoed, I.G., Boeke, A.J., van Voorst Vader, P.C., Schirm, J., de Blok, S., van Den Hoek, J.A., van Doornum, G.J., and Meijer, C.J., et al. 2000. Urogenital Chlamydia trachomatis serovars in men and women with a symptomatic or asymptomatic infection: An association with clinical manifestations? J. Clin. Microbiol. 38: 22922296. Nei, M. and Kumar, S. 2000. Molecular evolution and phylogenetics. Oxford University Press, New York. Ogata, H., Renesto, P., Audic, S., Robert, C., Blanc, G., Fournier, P.E., Parinello, H., Claverie, J.M., and Raoult, D. 2005. The genome sequence of Rickettsia felis identifies the first putative conjugative plasmid in an obligate intracellular parasite. PLoS Biol. 3: e248.[CrossRef][Medline] Read, T.D., Myers, G.S., Brunham, R.C., Nelson, W.C., Paulsen, I.T., Heidelberg, J., Holtzapple, E., Khouri, H., Federova, N.B., and Carty, H.A., et al. 2003. Genome sequence of Chlamydophila caviae (Chlamydia psittaci GPIC): Examining the role of niche-specific genes in the evolution of the Chlamydiaceae. Nucleic Acids Res. 31: 21342147. Ridderhof, J.C. and Barnes, R.C. 1989. Fusion of inclusions following superinfection of HeLa cells by two serovars of Chlamydia trachomatis. Infect. Immun. 57: 31893193. Robertson, D.L., Hahn, B.H., and Sharp, P.M. 1995. Recombination in AIDS viruses. J. Mol. Evol. 40: 249259.[CrossRef][Medline] Saitou, N. and Nei, M. 1987. The neighbor-joining method: A new method for reconstructing phylogenetic trees. Mol. Biol. Evol. 4: 406425.[Abstract] Salminen, M.O., Carr, J.K., Burke, D.S., and McCutchan, F.E. 1995. Identification of breakpoints in intergenotypic recombinants of HIV type 1 by bootscanning. AIDS Res. Hum. Retroviruses 11: 14231425.[Medline] Smith, J.M. 1992. Analyzing the mosaic structure of genes. J. Mol. Evol. 34: 126129.[Medline] Smith, J.M., Smith, N.H., ORourke, M., and Spratt, B.G. 1993. How clonal are bacteria? Proc. Natl. Acad. Sci. 90: 43844388. Stephens, R.S., Kalman, S., Lammel, C., Fan, J., Marathe, R., Aravind, L., Mitchell, W., and Olinger, L. 1998. Genome sequence of an obligate intracellular pathogen of humans: Chlamydia trachomatis. Science 282: 754759. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||